EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City: San Mateo
State: California
Zip:
Country: United States
EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2023 | Series A | $0 |
Google Ventures Mubadala Capital Ventures Polaris Partners Vivo Capital Google Ventures Mubadala Capital Ventures Polaris Partners Vivo Capital Google Ventures Mubadala Capital Ventures Polaris Partners Vivo Capital Google Ventures Mubadala Capital Ventures Polaris Partners Vivo Capital |
3/2023 | Series A | 4 | $50M |
Google Ventures Mubadala Capital Ventures Polaris Partners Vivo Capital Google Ventures Mubadala Capital Ventures Polaris Partners Vivo Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|